Crozet, Carole, 1971-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Carole Crozet researcher ORCID ID = 0000-0002-7292-7046
VIAF ID: 689146284498815332344 (Personal)
Permalink: http://viaf.org/viaf/689146284498815332344
Preferred Forms
4xx's: Alternate Name Forms (1)
Works
| Title | Sources |
|---|---|
| Cationic phosphorus-containing dendrimers reduce prion replication both in cell culture and in mice infected with scrapie |
|
| Cellular pathogenesis in prion diseases. |
|
| The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer |
|
| Cellules souches embryonnaires et neurales humaines : quand la PrP et l'APP "s'en mêlent" ou "s'emmêlent |
|
| Comparative proteomic analysis of human mesenchymal and embryonic stem cells: towards the definition of a mesenchymal stem cell proteomic signature. |
|
| Effective gene therapy in a mouse model of prion diseases |
|
| From PrPC physiological roles to prion infection : regulation/dysregulation of the PDK1/TACE alpha-secretase signaling module. |
|
| Generation of induced pluripotent stem cells (iPSCs) IRMBi002-A from an Alzheimer's disease patient carrying a D694N mutation in the APP gene |
|
| High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. |
|
| Human embryonic and neural stem cells : when PrP and APP are mixed. |
|
| Impact des pesticides sur l'agrégation des amyloïdes dans différents modèles de maladies neurodégénératives |
|
| Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations. |
|
| De la fonction physiologique de la protéine prion cellulaire aux maladies neurodégénératives amyloïdes |
|
| Light neuron interaction : from photobiomodulation to optical heating |
|
| Lithium as a disease-modifying agent for prion diseases |
|
| Low grade cerebral tumors : development of in vitro and in vivo models for designing innovative therapeutic approaches. |
|
| Des maladies à prions à la maladie d'Alzheimer : vers l'identification de mécanismes communs de neurodégénérescence |
|
| Maladies à prions : vers le développement d'une thérapie génique et cellulaire |
|
| Mieux comprendre le gène PTK2B, un facteur de risque de la maladie d'Alzheimer, par l'utilisation de neurones dérivés de cellules souches pluripotentes induites humaines. |
|
| Neurodegenerative diseases and oxidative stress. |
|
| Peripheral circulation of the prion infectious agent in transgenic mice expressing the ovine prion protein gene in neurons only. |
|
| Prion diseases and adult neurogenesis: how do prions counteract the brain's endogenous repair machinery? |
|
| Prion-like propagation of alpha-synuclein in reconstructed neural networks. |
|
| Prion propagation in cultured cells. |
|
| Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases |
|
| Prions diseases : towards the development of gene and cell therapy.. |
|
| [Prions: where do we stand 20 years after the appearance of bovine spongiform encephalopathy?] |
|
| Probing the Alzheimer's disease risk gene PTK2B using human-derived induced neurons |
|
| Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin. |
|
| Scrapie strain transmission studies in ovine PrP transgenic mice reveal dissimilar susceptibility |
|
| Souris transgéniques pour la protéine prion ovine : transmission d'encéphalopathies subaiguës spongiformes transmissibles naturelles et expérimentales : contribution à la caractérisation des maladies à prions |
|
| Study of astrocytic perturbations under the influence of apolipoprotein E4 : implications and applications in Alzheimer's disease. |
|
| Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorder. |
|
| Transmission and characterization of bovine spongiform encephalopathy sources in two ovine transgenic mouse lines (TgOvPrP4 and TgOvPrP59). |
|
| Tumeurs cérébrales de bas grade : élaboration de modèles in vitro et in vivo pour le développement de thérapies innovantes |
|
| Voies de signalisation dépendantes de la protéine prion : de la physiologie à la pathologie |
|
